All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for EXELIXIS, INC. · Oncology-focused biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income · posted Apr 18, 2025

Official filing document

Bills named in this filing 1

S 5029
Small Biotech Innovation Act

Lobbying activity 3

Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029, 118th Congress).

Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program. Issues related to biopharmaceutical intellectual property and patent matters.

Taxation/Internal Revenue Code

Issues related to research and development (R&D) tax credits.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.